首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi

市場調查報告書

商品編碼

1448253

全球微陣列分析市場：市場規模、佔有率、成長分析 - 按類型、應用、產業預測（2024-2031）

Global Microarray Analysis Market Size, Share, Growth Analysis, By Type(DNA, Protein and others), By Application(Research applications, drug discovery) - Industry Forecast 2024-2031

出版日期: 2024年03月07日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球微陣列分析市場規模將於2022年達到50.6億美元，2023年達到55.1億美元，2024-2031年預測期間複合年成長率為8.8%，2031年預計將達到108億1000萬美元。

全球微陣列分析市場正在迅速擴大，是生物技術產業的一個高度先進的領域。微陣列分析涉及用於同時檢查大量基因或基因變體的表達水平的高通量技術。該市場主要是由個人化醫療需求不斷成長、基因組研究不斷進步以及慢性病患病率不斷上升所推動的。微陣列涵蓋廣泛的應用，包括基因表現表現譜、基因型鑒定、磊晶和生物標記發現。

微陣列技術的出現徹底改變了基因組學和分子生物學研究，使研究人員能夠研究廣泛的基因表現模式，識別與疾病相關的基因，並加速藥物發現過程。此外，微陣列分析與次世代定序和生物資訊等其他最尖端科技的整合進一步放大了其潛力並推動了市場成長。

傳統上，北美由於其成熟的研究基礎設施和對基因組學研究的大量投資而主導了該市場。然而，由於新興國家對精準醫療的日益關注以及微陣列技術的採用增加，亞太地區預計將顯著成長。

隨著基因組科學的不斷發展，微陣列分析市場有望實現顯著成長和創新。這樣的軌跡預計將推動個人化醫療、診斷和治療開發的進步，並塑造醫療保健的未來模式。

Bio-Rad Laboratories（US）
Agilent Technologies, Inc.（US）
Thermo Fisher Scientific Inc.（US）
Illumina, Inc.（US）
PerkinElmer Inc.（US）
Merck KGaA（Germany）
GE Healthcare（US）
Molecular Devices, LLC（US）
Arrayit Corporation（US）
Microarrays, Inc.（US）
BioGenex（US）
Oxford Gene Technology（OGT）（UK）
Qiagen NV（Netherlands）
Roche Diagnostics（Switzerland）
Fluidigm Corporation（US）
Affymetrix（US）
Agendia NV（Netherlands）
Applied Microarrays（US）
Biocompare（US）
Eppendorf AG（Germany）

簡介目錄

Product Code: SQMIG35J2057

The Global Microarray Analysis Market size was valued at USD 5.06 billion in 2022 and is poised to grow from USD 5.51 billion in 2023 to USD 10.81 billion by 2031, growing at a CAGR of 8.8% in the forecast period (2024-2031).

The Global Microarray Analysis Market is rapidly expanding and represents a highly advanced sector within the biotechnology industry. Microarray analysis involves a high-throughput technique used to simultaneously examine the expression levels of numerous genes or genetic variations. This market is primarily fueled by escalating demands for personalized medicine, continual advancements in genomic research, and the increasing prevalence of chronic illnesses. It encompasses a broad spectrum of applications, including gene expression profiling, genotyping, epigenetics, and biomarker discovery.

The emergence of microarray technologies has revolutionized genomics and molecular biology research by empowering researchers to investigate extensive gene expression patterns, identify genes associated with diseases, and facilitate drug discovery processes. Moreover, the integration of microarray analysis with other cutting-edge technologies like next-generation sequencing and bioinformatics has further amplified its potential and spurred market growth.

Traditionally, North America has been the dominant force in this market, benefiting from its well-established research infrastructure and substantial investments in genomics research. However, substantial growth is anticipated in the Asia-Pacific region, fueled by a burgeoning focus on precision medicine and an increasing adoption of microarray technologies in emerging economies.

As genomic science continues to evolve, the microarray analysis market is poised for significant growth and innovation. This trajectory is expected to drive advancements in personalized medicine, diagnostics, and therapeutic development, shaping the future landscape of healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microarray Analysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microarray Analysis Market Segmental Analysis

Worldwide Microarray Analysis Markets are divided based on geography, type, and application. The market can be divided into segments according on type, such as DNA, Protein, and others. The market is divided into segments according to application, including illness diagnostics, drug discovery, and research applications. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.

Drivers of the Global Microarray Analysis Market

The growing need for personalized medication is one of the major factors propelling the global microarray analysis market. By customizing medical care to each patient according to their genetic composition, personalized medicine seeks to provide more accurate and potent treatments. Microarray analysis is essential to personalized therapy since it helps identify genetic variants linked to disease and provides comprehensive genomic information. The demand for microarray analysis is being driven by the increasing global use of personalized medicine techniques, which is also bolstering market growth.

Restraints in the Global Microarray Analysis Market

The high cost of microarray technology and analysis is a major barrier to the growth of the global microarray analysis market. Because microarray platforms, reagents, and instruments can be costly, some medical facilities and research institutes with limited funding may find it difficult to use them. The intricacy of the data analysis process and the need for specific knowledge might further raise the final cost. The high expense of microarray analysis can be a barrier to its broad use and commercial expansion, particularly in environments with limited resources. To overcome this constraint, efforts to lower expenses and raise affordability-such as improved processes and technological advancements-are crucial.

Market Trends of the Global Microarray Analysis Market

The integration of microarray analysis with other omics technologies is a significant industry development in the global microarray analysis market. In order to improve data analysis and interpretation, this movement combines microarray analysis with other cutting-edge technologies including next-generation sequencing (NGS) and bioinformatics. Researchers can get a complete picture of the genome, transcriptome, and epigenome by combining NGS and microarray analysis. This allows for a more thorough and in-depth examination of genetic variants and gene expression. With the help of this trend, scientists can better understand disease mechanisms, intricate biological processes, and applications of personalized medicine by combining the strengths of many technologies. Microarray analysis in conjunction with other omics technologies fosters synergistic developments and opens the door to more thorough and multidimensional molecular profiling methods.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Microarray Analysis Market by Type

Market Overview
DNA
Protein and others

Global Microarray Analysis Market by Application

Market Overview
Research applications
drug discovery
disease diagnostics and others

Global Microarray Analysis Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Devices, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arrayit Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microarrays, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioGenex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Gene Technology (OGT) (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Affymetrix (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agendia NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Microarrays (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocompare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments